|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.84 EUR | +2.58% |
|
+3.84% | +8.05% |
| 07:02am | Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal | RE |
| 06-10 | Intron Health Upgrades GSK to Hold Rating, Lifts PT | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.54% | +3.50% | +20.45% | +16.49% | +8.38% | +44.04% | +161.55% | +419.75% | +1,476.91% | 1,013B | |
| +0.47% | +4.89% | +8.08% | -1.51% | +15.65% | +54.15% | +49.67% | +45.08% | +104.92% | 574B | |
| +0.78% | +0.56% | +11.55% | -0.65% | -1.00% | +18.13% | +64.24% | +95.99% | +277.46% | 397B | |
| -0.37% | +4.97% | +3.74% | -2.42% | -0.34% | +21.24% | +15.95% | -4.01% | +30.42% | 324B | |
| +0.85% | +0.18% | +0.56% | -6.26% | -1.54% | +24.50% | +14.78% | +62.81% | +254.98% | 280B | |
| +2.10% | +4.92% | +6.90% | +0.25% | +10.89% | +25.30% | +33.80% | +45.87% | +61.84% | 273B | |
| +5.26% | +2.81% | +7.80% | -5.92% | +8.55% | +21.76% | +63.46% | +46.35% | +132.10% | 182B | |
| -0.19% | -0.46% | -5.82% | +13.11% | -13.13% | -45.32% | -48.35% | +9.35% | +55.59% | 194B | |
| +4.33% | -1.87% | -5.06% | -13.17% | +3.28% | +15.98% | +62.82% | +84.34% | +50.95% | 151B | |
| +2.56% | +2.38% | +1.91% | -3.65% | +5.63% | +7.44% | -34.08% | -34.49% | -24.29% | 146B | |
| +2.92% | +0.93% | +2.61% | -4.76% | +5.90% | +13.89% | -11.79% | -15.17% | -20.90% | 114B | |
| +1.99% | +0.65% | +2.16% | -9.71% | -1.93% | -1.74% | +30.53% | +130.33% | +391.04% | 111B | |
| +0.38% | -0.18% | +4.21% | +0.07% | -7.76% | -12.01% | -19.70% | -14.17% | +9.80% | 105B | |
| -1.75% | +0.07% | -5.97% | -21.97% | -9.89% | -2.98% | +87.34% | +74.08% | +484.12% | 77.55B | |
| -0.73% | +6.00% | -3.45% | -11.96% | +4.10% | +15.30% | +10.93% | +33.61% | +10.54% | 49.92B | |
| -0.06% | -0.47% | -11.02% | -16.92% | -21.13% | -14.78% | +2.60% | -35.64% | +225.49% | 45.92B | |
| +1.19% | +0.65% | -3.48% | -10.56% | -3.30% | +28.95% | -29.97% | -33.07% | -59.36% | 40.15B | |
| +2.13% | -0.57% | -4.48% | +12.36% | +9.69% | +97.66% | +368.33% | +208.15% | -35.67% | 39.1B | |
| -1.21% | +1.27% | +2.11% | -8.82% | -10.89% | -16.14% | +3.94% | - | - | 40.13B | |
| Average | +1.25% | +2.60% | +1.73% | -4.00% | +0.06% | +15.55% | +43.48% | +62.18% | +190.33% | 218.78B | |
| Weighted average by Cap. | +1.53% | +3.67% | +7.85% | +1.71% | +4.27% | +25.63% | +63.44% | +136.01% | +459.29% |
- Stock Market
- Stocks
- GSK Stock
- GS71 Stock
- Sector GSK plc
Select your edition
All financial news and data tailored to specific country editions
